학술논문
Adverse Event Profile by Folate Receptor Status for Vintafolide and Pegylated Liposomal Doxorubicin in Combination, Versus Pegylated Liposomal Doxorubicin Alone, in Platinum-Resistant Ovarian Cancer: Exploratory Analysis of the Phase II PRECEDENT Trial
Document Type
Article
Author
Source
In: International Journal of Gynecological Cancer . (International Journal of Gynecological Cancer, 1 November 2016, 26(9):1580-1585)
Subject
Language
English
ISSN
15251438
1048891X
1048891X